0

Close
 
Upcoming Allied Market Research
2023
12 Channel Electrocardiograph Market

12 Channel Electrocardiograph Market

by Product Type (Resting ECG, Stress ECG, Holter ECG) and by End User (Hospitals, Clinics, Ambulatory surgical centers, Home settings, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A12572
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the 12 Channel Electrocardiograph Market

Request Now !

An electrocardiograph (ECG) is a non-invasive medical test that provides a graphical record of the voltage versus time by recording the electrical signals associated with cardiac activity for some time. It is used to determine a patient’s response to drug therapy, reveal changes in heart function, and diagnose and assist in the treatment of heart disease. Three different types of leads are included in the 12-lead system—precordial, unipolar, and bipolar. Each lead presents a different aspect of the heart’s electrical activity by producing ECG waveforms. Electrocardiographs record small voltages of about one millivolt between electrodes; these small variations directly correspond to the heart’s electrical activity.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the 12 channel electrocardiograph market.

Top Impacting Factors

  • Increase in cases of cardiovascular diseases, surge in geriatric populations, rise in demand for advanced equipment, and favorable government regulations are the factors that drive the growth of the 12 Channel Electrocardiograph market
  • In addition, increase in healthcare expenditure; availability of skilled professionals; partnerships & collaborations between key players to facilitate the launch of novel equipment in the market; rise in R&D activities; and technological advancements are factors, which boost the growth of the 12 Channel Electrocardiograph market.
  • However, lack of knowledge for proper handling of the device as well as complications associated with it, high cost of advanced ECG, unfavorable reimbursement policies, and saturation of market may hinder the market growth.
  • Contrarily, an increase in focus toward acquisitions, mergers, and product launches presents new pathways in the industry.

Market Trends

Product launch and acquisition is the key strategy adopted by players in the 12 channel electrocardiograph market.

In February 2018, Advanced Materials and Bioengineering Research (AMBER) collaborated with Johnson & Johnson to launch 3D bio print center of excellence

On April 2021, EDAN Instruments, Inc., one of the top ECG exporters in China, held its global launch event of the new generation 12-channel electrocardiograph SE-1202. It can be helpful to clinical practices. The high sampling frequency of SE-1202 can grab the signal and reflect it on the wave forms.

Key Benefits of the Report

  • This study presents the analytical depiction of the 12 Channel Electrocardiograph industries along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the 12 Channel Electrocardiograph market share.
  • The current market is quantitatively analyzed to highlight the 12 Channel Electrocardiograph market growth scenarios.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed 12 Channel Electrocardiograph market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the 12 Channel Electrocardiograph Report

  • Which are the leading players active in the 12 Channel Electrocardiograph market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "12 Channel Electrocardiograph "?
  • What is "12 Channel Electrocardiograph" Market prediction in the future?
  • Who are the leading global players in the "12 Channel Electrocardiograph" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "12 Channel Electrocardiograph" Market report?                                                                                                                                                                     

 12 Channel Electrocardiograph Market Report Highlights

Aspects Details
By Product Type
  • Resting ECG
  • Stress ECG
  • Holter ECG
    • Wired Holter
    • Wireless Holter
By End User
  • Hospitals
  • Clinics
  • Ambulatory surgical centers
  • Home settings
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players GE Healthcare, Spacelabs Healthcare, NIHON KOHDEN, Philips, Fukuda Denshi, BioTelemetry, Suzuken, Hill-Rom, Mindray Medical, Mortara Instrument
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: 12 CHANNEL ELECTROCARDIOGRAPH MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Resting ECG

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Stress ECG

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Holter ECG

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

      • 4.4.4. Wired Holter

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Wireless Holter

        • 4.4.4.1. Market Size and Forecast

  • CHAPTER 5: 12 CHANNEL ELECTROCARDIOGRAPH MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgical Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Home Settings

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: 12 CHANNEL ELECTROCARDIOGRAPH MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. 12 Channel Electrocardiograph Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada 12 Channel Electrocardiograph Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico 12 Channel Electrocardiograph Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France 12 Channel Electrocardiograph Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany 12 Channel Electrocardiograph Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy 12 Channel Electrocardiograph Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain 12 Channel Electrocardiograph Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK 12 Channel Electrocardiograph Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia 12 Channel Electrocardiograph Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe 12 Channel Electrocardiograph Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China 12 Channel Electrocardiograph Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan 12 Channel Electrocardiograph Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India 12 Channel Electrocardiograph Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea 12 Channel Electrocardiograph Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia 12 Channel Electrocardiograph Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand 12 Channel Electrocardiograph Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia 12 Channel Electrocardiograph Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia 12 Channel Electrocardiograph Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific 12 Channel Electrocardiograph Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil 12 Channel Electrocardiograph Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa 12 Channel Electrocardiograph Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia 12 Channel Electrocardiograph Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE 12 Channel Electrocardiograph Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina 12 Channel Electrocardiograph Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA 12 Channel Electrocardiograph Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. GE Healthcare

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Philips

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. BioTelemetry

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Suzuken

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Fukuda Denshi

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Hill-Rom

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Mortara Instrument

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. NIHON KOHDEN

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Spacelabs Healthcare

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Mindray Medical

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR RESTING ECG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR STRESS ECG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR HOLTER ECG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR HOME SETTINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA 12 CHANNEL ELECTROCARDIOGRAPH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 15. U.S. 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 16. U.S. 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. CANADA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 18. CANADA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE 12 CHANNEL ELECTROCARDIOGRAPH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. ITALY 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 29. ITALY 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. UK 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. UK 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC 12 CHANNEL ELECTROCARDIOGRAPH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. CHINA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 42. CHINA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. INDIA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 46. INDIA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA 12 CHANNEL ELECTROCARDIOGRAPH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. UAE 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. UAE 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA 12 CHANNEL ELECTROCARDIOGRAPH, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA 12 CHANNEL ELECTROCARDIOGRAPH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 75. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 76. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 77. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 78. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. PHILIPS: KEY EXECUTIVES
  • TABLE 80. PHILIPS: COMPANY SNAPSHOT
  • TABLE 81. PHILIPS: OPERATING SEGMENTS
  • TABLE 82. PHILIPS: PRODUCT PORTFOLIO
  • TABLE 83. PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. BIOTELEMETRY: KEY EXECUTIVES
  • TABLE 85. BIOTELEMETRY: COMPANY SNAPSHOT
  • TABLE 86. BIOTELEMETRY: OPERATING SEGMENTS
  • TABLE 87. BIOTELEMETRY: PRODUCT PORTFOLIO
  • TABLE 88. BIOTELEMETRY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. SUZUKEN: KEY EXECUTIVES
  • TABLE 90. SUZUKEN: COMPANY SNAPSHOT
  • TABLE 91. SUZUKEN: OPERATING SEGMENTS
  • TABLE 92. SUZUKEN: PRODUCT PORTFOLIO
  • TABLE 93. SUZUKEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. FUKUDA DENSHI: KEY EXECUTIVES
  • TABLE 95. FUKUDA DENSHI: COMPANY SNAPSHOT
  • TABLE 96. FUKUDA DENSHI: OPERATING SEGMENTS
  • TABLE 97. FUKUDA DENSHI: PRODUCT PORTFOLIO
  • TABLE 98. FUKUDA DENSHI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. HILL-ROM: KEY EXECUTIVES
  • TABLE 100. HILL-ROM: COMPANY SNAPSHOT
  • TABLE 101. HILL-ROM: OPERATING SEGMENTS
  • TABLE 102. HILL-ROM: PRODUCT PORTFOLIO
  • TABLE 103. HILL-ROM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. MORTARA INSTRUMENT: KEY EXECUTIVES
  • TABLE 105. MORTARA INSTRUMENT: COMPANY SNAPSHOT
  • TABLE 106. MORTARA INSTRUMENT: OPERATING SEGMENTS
  • TABLE 107. MORTARA INSTRUMENT: PRODUCT PORTFOLIO
  • TABLE 108. MORTARA INSTRUMENT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. NIHON KOHDEN: KEY EXECUTIVES
  • TABLE 110. NIHON KOHDEN: COMPANY SNAPSHOT
  • TABLE 111. NIHON KOHDEN: OPERATING SEGMENTS
  • TABLE 112. NIHON KOHDEN: PRODUCT PORTFOLIO
  • TABLE 113. NIHON KOHDEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. SPACELABS HEALTHCARE: KEY EXECUTIVES
  • TABLE 115. SPACELABS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 116. SPACELABS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 117. SPACELABS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 118. SPACELABS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. MINDRAY MEDICAL: KEY EXECUTIVES
  • TABLE 120. MINDRAY MEDICAL: COMPANY SNAPSHOT
  • TABLE 121. MINDRAY MEDICAL: OPERATING SEGMENTS
  • TABLE 122. MINDRAY MEDICAL: PRODUCT PORTFOLIO
  • TABLE 123. MINDRAY MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET SEGMENTATION
  • FIGURE 2. GLOBAL 12 CHANNEL ELECTROCARDIOGRAPH MARKET
  • FIGURE 3. SEGMENTATION 12 CHANNEL ELECTROCARDIOGRAPH MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN 12 CHANNEL ELECTROCARDIOGRAPH MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBAL12 CHANNEL ELECTROCARDIOGRAPH MARKET
  • FIGURE 11. 12 CHANNEL ELECTROCARDIOGRAPH MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR RESTING ECG, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR STRESS ECG, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR HOLTER ECG, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. 12 CHANNEL ELECTROCARDIOGRAPH MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR HOME SETTINGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. 12 CHANNEL ELECTROCARDIOGRAPH MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: 12 CHANNEL ELECTROCARDIOGRAPH MARKET
  • FIGURE 27. Top player positioning, 2022
  • FIGURE 28. GE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. PHILIPS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. PHILIPS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. PHILIPS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. BIOTELEMETRY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. BIOTELEMETRY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. BIOTELEMETRY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. SUZUKEN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. SUZUKEN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. SUZUKEN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. FUKUDA DENSHI: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. FUKUDA DENSHI: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. FUKUDA DENSHI: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. HILL-ROM: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. HILL-ROM: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. HILL-ROM: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. MORTARA INSTRUMENT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. MORTARA INSTRUMENT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. MORTARA INSTRUMENT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. NIHON KOHDEN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. NIHON KOHDEN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. NIHON KOHDEN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. SPACELABS HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. SPACELABS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. SPACELABS HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. MINDRAY MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. MINDRAY MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. MINDRAY MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
12 Channel Electrocardiograph Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers